Key insights
- Stratasys reported a Q1 2026 earnings miss and revenue decline, impacted by macroeconomic headwinds and cautious capital spending. However, strong growth in its parts manufacturing business, particularly from aerospace and defense clients, signals resilience in high-value sectors. This segment's momentum, especially in defense applications, could be a leading indicator for industrial automation and advanced manufacturing adoption, though overall performance remains mixed.
Stratasys Ltd. (NASDAQ:SSYS) presented its first-quarter 2026 results on May 7, revealing a mixed performance that sent shares down 4.32% to $8.85 in premarket trading. While the 3D printing company beat revenue expectations at $132.7 million versus the anticipated $131.8 million, it missed earnings per share forecasts, reporting a non-GAAP loss of $0.01 against an expected breakeven.
The quarter highlighted the company’s strategic pivot toward high-value aerospace and defense applications, even as macroeconomic headwinds from foreign exchange fluctuations and tariffs pressured profitability. CEO Dr. Yoav Zeif emphasized the company’s focus on "executing our strategy" for manufacturing penetration, particularly in mission-critical defense applications where demand continues to accelerate.
As shown in the following breakdown of revenue performance, Stratasys posted total revenue of $132.7 million in Q1 2026, representing a 2.4% year-over-year decline from $136.0 million in the prior-year period.
The revenue composition revealed divergent trends across business segments. Product revenue declined 5.3% year-over-year to $88.8 million, driven by systems sales of $28.8 million (down 7.7%) and consumables revenue of $60.0 million (down 4.2%). This weakness reflected continued customer caution on capital spending amid global economic uncertainty.
In contrast, the services segment demonstrated resilience with revenue of $43.9 million, up 4.0% year-over-year. Notably, Stratasys Direct—the company’s parts manufacturing business—delivered exceptional performance with 23% organic growth driven primarily by drone customers in the aerospace and defense sector.
CFO Eitan Zamir noted that "first quarter results reflect continued execution against the operational priorities" while maintaining EBITDA profitability and generating positive operating cash flow despite the challenging demand environment.
The presentation highlighted significant traction in the aerospace and defense market, which emerged as a key growth driver for the company’s long-term strategy.
Stratasys disclosed two major initiatives underscoring its expanding role in defense applications. The company is participating in the US Department of War’s JAMA IV Program, a multimillion-dollar initiative accelerating qualification and deployment of 3D-printed parts across military platforms. This positions Stratasys to capture a larger share of US defense additive manufacturing spending, which surged 83% in fiscal year 2026.
The company also highlighted its involvement in NASA’s Artemis II Moon Mission, where hundreds of parts produced with Stratasys Antero materials on FDM printers were deployed. With thousands of systems already deployed and over 100,000 parts shipped annually to defense customers, Stratasys has established certifications including AS9100, ISO 9001, CMMC, and ITAR compliance.
Dr. Zeif emphasized that "defense industry solutions are established, certified and operating at scale across active military platforms," positioning the company for durable, recurring demand as these parts become integrated into standard military workflows.
Beyond aerospace, Stratasys announced several product developments aimed at expanding its addressable market, particularly in the dental sector.
The company received CE Class IIA certification for its TrueDent polychromatic, monolithic 3D-printed denture solution—the first of its kind at this classification level in Europe. This certification opens access to a dental removables market projected to reach $2.45 billion by 2028 and expands Stratasys’ product range to include long-term intraoral applications, crowns, and bridges.
Materials expansion continued with ULTEM 1010 now available on the F3300 printer for aerospace-grade, high-temperature applications, optimized for composite tooling. The company also introduced ToughONE advanced material for functional prototyping on its J3/J5 platforms.
Software enhancements included the launch of Measurement-Based Warped Adaptive Modeling on GrabCAD Print Pro, which automatically corrects warping on the Origin P3 platform, reducing time and cost for complex parts production.
The following chart illustrates the gross margin trends across both GAAP and non-GAAP measures over the past five quarters:
Non-GAAP gross margin compressed to 46.3% in Q1 2026 from 48.3% in the prior-year period, reflecting unfavorable product mix and the impact of foreign exchange headwinds. Product gross margins on a non-GAAP basis reached 53.8%, while services margins stood at 31.0%.
Operating expenses increased significantly, as detailed in the quarterly comparison:
Non-GAAP operating expenses rose to $64.6 million (48.7% of revenues) from $62.6 million (46.0% of revenues) in Q1 2025, driven primarily by professional fees and currency impacts from the strengthening Israeli shekel.
The profitability overview reveals the cumulative impact of revenue pressure and expense growth:
The company reported a non-GAAP operating loss of $3.2 million compared to operating income of $3.0 million in the prior-year quarter. Adjusted EBITDA declined sharply to $2.0 million (1.5% of revenue) from $8.2 million (6.0% of revenue), with approximately $5.3 million of the year-over-year deterioration attributed to adverse foreign exchange and tariff impacts.
Despite profitability challenges, Stratasys maintained a robust financial position:
The company held $237.8 million in cash and short-term deposits with zero debt, while generating $2.4 million in operating cash flow during the quarter. Net working capital stood at $392.9 million, and inventory declined to $143.6 million as the company continued optimizing its asset base.
Management reaffirmed its full-year 2026 guidance despite the challenging first quarter:
The company projects revenues between $565 million and $575 million, with non-GAAP operating margins of 0.7% to 1.5%. Adjusted EPS is expected to range from $0.09 to $0.14, while adjusted EBITDA is forecasted at $25 million to $30 million (4.5% to 5.0% of revenue).
Notably, the guidance incorporates approximately $17 million in adverse impacts from foreign exchange and tariffs for the full year, including the $7 million impact on gross margins and $10 million on operating expenses. Management expects positive operating cash flow for 2026, though this remains subject to continued FX and tariff uncertainty.
CEO Zeif expressed confidence in the trajectory, stating that "strategic progress today reinforces the trajectory for tomorrow," with particular emphasis on the expanding defense pipeline and increased access to the multi-billion-dollar European dental vertical.
The presentation acknowledged several headwinds facing the business. Beyond the quantified $17 million impact from FX and tariffs, the company cited ongoing customer deliberation on capital expenditures amid macroeconomic uncertainty. The forward-looking statements section specifically referenced risks from "Israel’s recent preemptive or retaliatory wars against Iran and/or its sponsored terrorist organizations Hamas, Hezbollah, and, intermittently, the Houthis."
During the earnings call, analysts questioned the company’s ability to manage operating expenses and maintain profitability amid these challenges. Executives emphasized their focus on cost management and strategic investments in high-growth areas, particularly aerospace and defense, to offset near-term pressures.
With a beta of 1.86 and a 52-week trading range of $7.34 to $12.81, Stratasys shares exhibit higher volatility than the broader market. The 10.49% decline on the day of the earnings release reflected investor concern over the profitability trajectory, though management’s guidance for positive EPS in Q2 and Q3 suggests confidence in sequential improvement.
The company’s strategic positioning in defense applications—where it operates at scale with established certifications—combined with its debt-free balance sheet, provides a foundation for pursuing both organic and inorganic growth opportunities as the additive manufacturing market continues to evolve.
Full presentation:
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.
Most traders can read a chart. The hard part is the moment: entry window open, pattern forming, and you're still waiting for more confirmation. That's the conviction gap — and our chart analysis closes it. Unlike other AIs that just read data, our Vision AI literally "sees" your charts and hands you a complete trading plan: entry, stop-loss, and profit target in under 60 seconds. Know exactly what to do next, every time.